Giant paratesticular liposarcoma: A case report and review of the literature

Li,Zuwei; Zhou,Liang; Zhao,Liwen; Chen,Peijie; Liu,Yifeng; Ding,Yu; Sun,Shuolei; Yang,Shangqi; Lai,Yongqing

doi:10.3892/mco.2018.1577

Giant paratesticular liposarcoma: A case report and review of the literature

Authors:
- Zuwei Li
- Liang Zhou
- Liwen Zhao
- Peijie Chen
- Yifeng Liu
- Yu Ding
- Shuolei Sun
- Shangqi Yang
- Yongqing Lai
View Affiliations

Affiliations: Department of Urology, Peking University Shenzhen Hospital, Shenzhen 518036, P.R. China
Published online on: February 15, 2018 https://doi.org/10.3892/mco.2018.1577
Pages: 613-616

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Paratesticular liposarcoma is an infrequent tumor characterized by a growing, painless, inguinal or scrotal mass. Only about 200 cases have been reported as of yet in literature, however there are a few cases regarding giant paratesticular liposarcoma measuring over 10 cm. The disease may be commonly misdiagnosed prior to operation. Improper treatment tends to lead to local recurrence and distant metastasis. The current report presents a case of a 51‑year‑old patient with a large, painless right scrotum. Magnetic resonance imaging revealed a 7.8x5.8x10.4 cm nonhomogeneous space‑occupying lesion of the right testis, which was firstly diagnosed as a spermatocytoma. Following this, a radical orchiectomy of the right testis was performed, however, it appeared to be a dedifferentiated liposarcoma, following histopathological examination and immunohistochemistry. Due to the large size of the tumor, it is significant to report the characteristics, diagnosis and treatment of the similar cases. The current study additionally presents a supplementary review of previously published cases in literature and focuses on discussion regarding the clinical characteristics, diagnosis, histopathology and immunohistochemical features and treatment of this disease.

View Figures

View References

1	Reddy A, Grosberg SJ and Wpanick S: Intermittent cholestatic jaundice and nonmetastatic prostatic carcinoma. Arch Intern Med. 137:1616–1618. 1977. View Article : Google Scholar : PubMed/NCBI
2	Darnell RB and Posner JB: Paraneoplastic syndromes. Oxford Uni Press; pp. 4822011
3	Pelosof LC and Gerber DE: Paraneoplastic syndromes: An approach to diagnosis and treatment. Mayo Clin Proc. 85:pp. 838–854. 2010; View Article : Google Scholar : PubMed/NCBI
4	Stauffer M: Nephrogenic hepatomegaly. Gastroenterol. 40:6941961.
5	Dancygier H: Clinical hepatology: Principles and practice of hepatobiliary diseases. 2. Springer; 2010, View Article : Google Scholar
6	Perisic VN, Howard ER, Mihailovic T, Vujanic G, Milovanovic D and Ivanovski P: Cholestasis caused by biliary botryoid sarcoma. Eur J Pediatr Surg. 1:242–243. 1991. View Article : Google Scholar : PubMed/NCBI
7	Tiede DJ, Tefferi A, Kochhar R, Thompson GB and Hay ID: Paraneoplastic cholestasis and hypercoagulability associated with medullary thyroid carcinoma. Resolution with tumor debulking. Cancer. 73:702–705. 1994. View Article : Google Scholar : PubMed/NCBI
8	Patel KJ, Latif SU and de Calaca WM: An unusual presentation of precursor T cell lymphoblastic leukemia/lymphoma with cholestatic jaundice: Case report. J Hematol Oncol. 2:122009. View Article : Google Scholar : PubMed/NCBI
9	Alirhayim Z, Dyal H, Alarhayem A and Donthireddy V: Non-Hodgkin's lymphoma: A cause of paraneoplastic cholestasis. BMJ Case Rep. 2013(pii): bcr20130097142013.PubMed/NCBI
10	Fraisse TC, Damigny A, di Castri A, de Wazières B and Fourcade J: Leiomyosarcoma and Stauffer syndrome. Rev Med Interne. 22:1116–1118. 2001.(In French). View Article : Google Scholar : PubMed/NCBI
11	Barta SK, Yahalom J, Shia J and Hamlin PA: Idiopathic cholestasis as a paraneoplastic phenomenon in Hodgkin's lymphoma. Clin Lymphoma Myeloma. 7:77–82. 2006. View Article : Google Scholar : PubMed/NCBI
12	Pandey J and Bhowmik KT: Chronic lymphocytic leukemia presenting as jaundice. Indian J Gastroenterol. 17:281998.PubMed/NCBI
13	Karakolios A, Kasapis C, Kallinikidis T, Kalpidis P and Grigoriadis N: Cholestatic jaundice as a paraneoplastic manifestation of prostate adenocarcinoma. Clin Gastroenterol Hepatol. 1:480–483. 2003. View Article : Google Scholar : PubMed/NCBI
14	Bloch WE and Block NL: Metastatic prostate cancer presenting as obstructive jaundice. Urology. 40:456–457. 1992. View Article : Google Scholar : PubMed/NCBI
15	Cole A, Mendelblatt D, Aguayo J, Mathew A, Martin E and Vesely DL: Metastatic prostate cancer (with prostate-specific antigen of 9996) presenting as obstructive jaundice. Am J Med Sci. 319:118–122. 2000. View Article : Google Scholar : PubMed/NCBI
16	Nguyen V, Gurney H and van der Poorten D: Paraneoplastic hepatic dysfunction in metastatic prostate cancer: The role of cytokine dysregulation. J Clin Oncol. 29:e21–e23. 2011. View Article : Google Scholar : PubMed/NCBI
17	Kuramoto T, Senzaki H, Koike H, Yamagiwa K, Tamura S, Fujimoto T and Inagaki T: Cholestatic jaundice as a paraneoplastic manifestation of prostate cancer. Case Rep Urol. 2013:3037272013.PubMed/NCBI
18	Ben-Ishay D, Slavin S, Levij IS and Eliakim M: Obstructive jaundice associated with carcinoma of the prostate. Isr J Med Sci. 11:838–844. 1975.PubMed/NCBI
19	Koruk M, Büyükberber M, Savaş C and Kadayifçi A: Paraneoplastic cholestasis associated with prostate carcinoma. Turkish J Gastroenterol. 15:53–55. 2004.
20	Shah SH: Paraneoplastic liver dysfunction in prostate cancer. J Pain Symptom Manage. 32:511–513. 2006. View Article : Google Scholar : PubMed/NCBI
21	National Cancer Institute, . Cancer of the prostate-SEER stat fact sheets. 2016.
22	Blay JY, Rossi JF, Wijdenes J, Menetrier-Caux C, Schemann S, Négrier S, Philip T and Favrot M: Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer. 72:424–430. 1997. View Article : Google Scholar : PubMed/NCBI
23	Trauner M, Fickert P and Stauber RE: Inflammation-induced cholestasis. J Gastroenterol Hepatol. 14:946–959. 1999. View Article : Google Scholar : PubMed/NCBI